Vivos Therapeutics, Inc. (VVOS) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Highlands Ranch, CO, アメリカ. 現CEOは R. Kirk Huntsman.
VVOS を有する IPO日 2020-12-11, 109 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $7.95M.
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
